CSF2 and congenital rubella syndrome: The finding GM-CSF knock-out in CAR T cells decreases the level of GM-CSF in vivo55,56 suggests that CAR T cells may be the main source of GM-CSF in the pathogenesis of CAR T cell therapy associated CRS.